Mahathir Bayena

Strategy's Stretch preferred security (STRC) fell as low as $97.11 before closing at $98.57, slipping below the company's intended $100 target level and drawing attention to its ability to continue raising capital through at-the-market share issuance.

The XRP Ledger recorded significant growth in the first quarter of 2026, with its tokenised real-world asset market expanding 124% quarter-on-quarter to reach $2.25 billion, according to a report from Messari.

Texas has moved closer to holding Bitcoin directly after appointing a five-member advisory committee to oversee the state's Strategic Bitcoin Reserve and advise on custody, valuation and asset management.

Tempus AI (NASDAQ:TEM) announced that the U.S. Food and Drug Administration (FDA) has granted approval for a tumor-only indication for its xT CDx next-generation sequencing platform.

AbbVie (NYSE:ABBV) has secured authorization from the European Commission for an expanded label of its oncology drug VENCLYXTO (venetoclax) to treat adult patients with previously untreated chronic lymphocytic leukemia (CLL).

Genesco (NYSE:GCO) reported first-quarter revenue that surpassed Wall Street expectations, driven by a modest recovery in brick-and-mortar retail traffic that countered stagnant growth across its e-commerce segments.

BeOne Medicines (NASDAQ:ONC) is moving to advance the treatment paradigm for chronic lymphocytic leukemia (CLL) with extensive long-term follow-up data slated for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Gemini has partnered with SpaceXAI to introduce an artificial intelligence-powered feature for its prediction markets platform that delivers personalised market feeds to users.

Bit Digital's first Ether purchase since October has fallen into the red after the company bought $20 million worth of ETH shortly before a sharp market decline.

Elanor Investors Group (ASX:ENN) halted its proposed acquisition of Singapore-based Firmus Capital due to regulatory approval delays.